Topline A Covid-19 antibody treatment developed by Vir Biotechnology and GlaxoSmithKline is still capable of neutralizing the infectious omicron subvariant, BA.2, Vir announced Thursday, offering earl...
Topline A Covid-19 antibody treatment developed by Vir Biotechnology and GlaxoSmithKline is still capable of neutralizing the infectious omicron subvariant, BA.2, Vir announced Thursday, offering earl...